
3,4-Dibenzyloxyphenethylamine hydrochloride | CAS:1699-56-5
3,4-Dibenzyloxyphenethylamine hydrochloride
- 名称:3,4-(二苄氧基)苯乙胺盐酸盐 | 3,4-Dibenzyloxyphenethylamine hydrochloride
- CAS号:1699-56-5
- 别名:3,4-Bis(benzyloxy)phenethylamine hydrochloride
- 分子式:C22H23NO2.HCl
- 分子量:369.88
- EINESC号:216-924-4
产品描述
物理化学性质
熔点 | 131-133 ºC |
---|
安全数据
没有数据 | 没有数据 |
---|
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
A novel method for local administration of strontium from implant surfaces.Johan Forsgren et al.Journal of materials science. Materials in medicine, 21(5), 1605-1609 (2010-02-18)
Comparative evaluation of the efficacy of three commercially available toothpastes on dentin hypersensitivity reduction: an eight-week clinical study.Raffaella Docimo et al.The Journal of clinical dentistry, 22(4), 121-127 (2011-01-01)
Advances in the clinical management of dentin hypersensitivity: a review of recent evidence for the efficacy of dentifrices in providing instant and lasting relief.D Cummins The Journal of clinical dentistry, 22(4), 100-107 (2011-01-01)
Comparison of the effects on dentin permeability of two commercially available sensitivity relief dentifrices.R Patel et al.The Journal of clinical dentistry, 22(4), 108-112 (2011-01-01)
An in situ study investigating dentine tubule occlusion of dentifrices following acid challenge.Ryan C Olley et al.Journal of dentistry, 40(7), 585-593 (2012-04-10)
An in vitro investigation of two currently marketed dentin tubule occlusion dentifrices.Charles R Parkinson et al.The Journal of clinical dentistry, 22(1), 6-10 (2011-02-05)
Development of an in situ methodology for the clinical evaluation of dentine hypersensitivity occlusion ingredients.N C A Claydon et al.The Journal of clinical dentistry, 20(5), 158-166 (2009-11-12)
Dentine hypersensitivity and the placebo response. A comparison of the effect of strontium acetate, potassium nitrate and fluoride toothpastes.N X West et al.Journal of clinical periodontology, 24(4), 209-215 (1997-04-01)
Clinical efficacy in reducing dentin hypersensitivity of a dentifrice containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride compared to a dentifrice containing 8% strontium acetate and 1040 ppm fluoride under consumer usage conditions before and after switch-over.T Schiff et al.The Journal of clinical dentistry, 22(4), 128-138 (2011-01-01)
Clinical evidence for the superior efficacy of a dentifrice containing 8.0% arginine and calcium carbonate in providing instant and lasting relief of dentin hypersensitivity.D Cummins The Journal of clinical dentistry, 22(4), 97-99 (2011-01-01)
A comparative in vitro study investigating the occlusion and mineralization properties of commercial toothpastes in a four-day dentin disc model.Charles R Parkinson et al.The Journal of clinical dentistry, 22(3), 74-81 (2011-09-13)
Development of an acid challenge-based in vitro dentin disc occlusion model.Charles R Parkinson et al.The Journal of clinical dentistry, 21(2), 31-36 (2010-07-31)
A comparative clinical study investigating the efficacy of a dentifrice containing 8% strontium acetate and 1040 ppm fluoride in a silica base and a control dentifrice containing 1450 ppm fluoride in a silica base to provide immediate relief of dentin hypersensitivity.Stephen Mason et al.The Journal of clinical dentistry, 21(2), 42-48 (2010-07-31)
Investigation of dentinal tubule occlusion using FIB-SEM milling and EDX.J S Earl et al.The Journal of clinical dentistry, 21(2), 37-41 (2010-07-31)
A comparative clinical study investigating the efficacy of a test dentifrice containing 8% strontium acetate and 1040 ppm sodium fluoride versus a marketed control dentifrice containing 8% arginine, calcium carbonate, and 1450 ppm sodium monofluorophosphate in reducing dentinal hypersensitivity.Nathan Hughes et al.The Journal of clinical dentistry, 21(2), 49-55 (2010-07-31)
Comparison of clinical efficacy of three toothpastes in reducing dentin hypersensitivity.Yiming Li et al.The Journal of clinical dentistry, 22(4), 113-120 (2011-01-01)
Evidence for the efficacy of an 8% strontium acetate dentifrice for instant and lasting relief of dentin hypersensitivity.Teresa Layer et al.The Journal of clinical dentistry, 21(2), 56-58 (2010-07-31)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!